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Abstract
Advances in cancer prevention, detection, and treatment have led to reductions in morbidity and 
premature mortality and improvements in quality of life. However, not all Americans have 
benefitted equally from these advances, and certain populations experience continued disparities 
in cancer care. Although research and public health efforts have highlighted the experiences of 
some groups, other populations have been relatively understudied, such as lesbian, gay, bisexual, 
and transgender (LGBT) individuals. Public health efforts in surveillance, research, programs, and 
partnerships can provide opportunities to advance health equity for LGBT at the population level 
and lead to better health outcomes for LGBT individuals with cancer.
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Introduction
NOT ALL AMERICANS BENEFIT equally from recent improvements in life expectancy and overall 
health. Differences in the incidence, prevalence, and mortality of disease exist among 
specific population groups. While health disparities have been routinely characterized by 
race or ethnicity, the term also refers to gender, age, education, income, social class, 
disability, geographic location, and sexual orientation since these all have a direct or indirect 
impact on an individual’s health.1
Members of the lesbian, gay, bisexual, and transgender (LGBT) community have specific 
health needs that are often associated with social and structural inequities. The U.S. 
Department of Health and Human Services (HHS) has worked to promote equal treatment, 
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provide tailored resources, identify specific health needs, improve access to health coverage 
for LGBT Americans, and improve collection of sexual orientation and gender identity 
variables in population-based data systems.2,3 As the nation’s health protection agency 
within HHS, the Centers for Disease Control and Prevention (CDC) strives to improve the 
health of LGBT communities by increasing awareness of health care access issues and 
supporting culturally appropriate and relevant programs and science. Since LBGT 
populations may be disproportionally affected by certain cancer types, CDC’s Division of 
Cancer Prevention and Control (DCPC) takes a public health approach to identify 
opportunities that promote health equity and to establish cancer prevention and control 
priorities for LGBT populations.4 This article provides an overview of DCPC’s current and 
potential future work in LGBT populations in surveillance and research, public health 
programs, and public health partnerships.
Public Health Surveillance and Research
In 2011, The Institute of Medicine (IOM) identified research gaps and opportunities for 
LGBT populations, including the need for more LGBT-specific data.5 Public health 
surveillance and research activities are critical for planning, evaluating, and building the 
evidence base for public health programs. DCPC uses two major types of surveillance 
systems for cancer data: cancer registries and behavior-based surveys.
The National Program of Cancer Registries
CDC’s National Program of Cancer Registries (NPCR) supports 48 central cancer registries 
to collect data on all invasive cancer occurrences. Together, NPCR registries and those 
funded through the National Cancer Institute’s Surveillance, Epidemiology, and End Results 
(SEER) Program make national cancer incidence and mortality data available through 
several avenues.6 Numerous factors dictate the type of information that can be successfully 
collected on the over one million invasive cancer cases diagnosed annually, which have 
important implications for collecting information on sexual orientation and gender identity. 
One of the most critical factors is that data collection occurs by abstracting information from 
existing medical records. In contrast with information on age and diagnosis, sexual 
orientation is usually not available systematically in medical records and is not available for 
consistent data capture by cancer registrars. Unlike behavior-based surveys, cancer registrars 
do not speak to patients directly as part of state-mandated cancer reporting.
Cancer registries do collect some data on gender identity, including whether the patient is 
male, female, hermaphrodite, or transsexual. Recently, the North American Association of 
Central Cancer Registries modified sex categories to include: transgender, natal male; and 
transgender, natal female.7 However, the validity and stability of these counts are not yet 
known and the relative cancer burden for these groups cannot be measured without 
corresponding population data from the U.S. Census.
Efforts to carefully evaluate the most effective approaches to studying cancer in the LGBT 
community need to continue. Until collection of sexual orientation is universally 
acknowledged by the medical community as critical to care and diagnoses, and clinicians 
consistently include this information in medical charts, nation-wide collection of these data 
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through modern cancer registries is likely not feasible. However, focused data collection 
efforts in smaller geographic areas can be used to continue to assess risk factors for cancer 
in LGBT populations and study how to best decrease cancer risks and barriers to care in 
these populations.
Behavioral surveillance using survey methods
Behavioral surveillance collects data directly from individuals and presents an opportunity 
to better understand cancer disparities among LGBT populations. CDC is collaborating with 
other HHS agencies to develop and test questions on sexual orientation and gender identity 
on population-based data systems that monitor the Healthy People 2020 objectives.2 The 
inclusion of sexual orientation questions on surveys sometimes raises concerns that the topic 
is too controversial and may result in excessive missing or inaccurate data due to refusals to 
self-report. Research suggests, however, that refusal rates for sexual orientation questions 
are significantly lower than household income questions and comparable to race/ethnicity 
and weight questions.8 Additional research has found that most patients believed it was 
important for their health care provider to collect sexual orientation and gender identity 
information and were willing to share the information with providers.9
A module that included questions on gender identity and sexual orientation was available for 
the 2014 Behavioral Risk Factor Surveillance System (BRFSS) questionnaire.10 Thirty-one 
states adopted the module or used a variation on the questions and received technical and 
financial assistance from HHS. According to The Fenway Institute, 25 states have included 
some sexual orientation questions in their BRFSS surveys at least once from 1995–2011.11 
The collection and analysis of these questions are an important start to understanding the 
health behaviors of LGBT populations. Whereas health disparity measures such as race and 
ethnicity, age, education, and income are collected annually on the BRFSS questionnaire, 
sexual orientation is not currently collected by all grantees. As the need for data-driven, 
state-based public health programs specific for LGBT populations continues to increase, 
including sexual orientation as an additional health disparity measure in the demographics 
section of the BRFSS questionnaire would provide a better opportunity to assess disparities 
among sexual minorities, especially as they relate to cancer.
National-level, sexual orientation data have been collected by two population-based surveys: 
the National Health Interview Survey (NHIS) and the Youth Risk Behavior Survey (YRBS). 
NHIS is a nationally representative sample of non-institutionalized adults aged 18 and older 
and the YRBS includes a nationally representative sample of students in grades 9–12 
attending U.S. high schools.12,13 The NHIS collected sexual orientation data in 2013 and 
2015 and the YRBS included sexual orientation items on the 2015 national survey.14,15 
Taken together, efforts to collect sexual orientation data on behavioral surveys can begin to 
provide the data-driven foundation for development of new or modification of existing 
cancer prevention and control programs tailored for LGBT populations.
Public Health Programs
CDC promotes adoption of evidence-based cancer screening interventions for underserved 
populations who experience a disproportionate burden of cancer through two programs. The 
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National Breast and Cervical Cancer Early Detection Program (NBCCEDP) provides access 
to breast and cervical cancer screening and diagnostic services to low-income, uninsured and 
underinsured women.16 The Colorectal Cancer Control Program (CRCCP) intends to 
increase colorectal cancer screening rates by implementing evidence-based, population-level 
strategies to promote colorectal cancer screening and providing screening services.17 Since 
neither program includes gender as an eligibility requirement, CDC is able to address the 
cancer screening needs of LGBT populations who may be uninsured or underinsured. For 
example, transgender men and women who have taken hormones and meet program 
eligibility requirements may receive breast cancer screening through the NBCCEDP. Also, 
transgender men who have not had a bilateral mastectomy or hysterectomy continue to be 
eligible for breast and cervical cancer screening.2
The National Comprehensive Cancer Control Program (NCCCP) supports a collaborative, 
data-driven process to reduce cancer risk, find cancers earlier, improve treatments, increase 
the number of people who survive cancer, and improve the quality of life for cancer 
survivors.18 One of the NCCCP priorities includes promoting health equity as it relates to 
cancer control. Of the 58 programs funded by CDC, there are 5 that include objectives 
related to LGBT populations. As the surveillance data for LGBT populations become readily 
available, more NCCCP programs may include objectives that specifically address this 
population.
Public Health Partnerships
Based on the tenants of comprehensive cancer control, DCPC has partnered with CDC’s 
Office on Smoking and Health to fund the Consortium of National Networks to Impact 
Populations Experiencing Tobacco-Related and Cancer Health Disparities (National 
Networks Consortium).19 It is intended to address tobacco use and cancer in underserved 
communities in a variety of ways, including enhancing the quality and performance of 
public health data and information systems and public health practices and services. The 
National Networks Consortium supports including sexual orientation in tobacco surveillance 
surveys.20 One of the funded National Networks Consortium partners is LGBT HealthLink 
and focuses on addressing health disparities in LGBT populations through building capacity 
for community collaborations, providing education, helping to bridge communication and 
outreach gaps among LGBT communities and local health providers, and disseminating 
research findings to support program efforts.21
Conclusion
Identifying cancer disparities among LGBT populations and effectively monitoring efforts 
to reduce them has been limited by a lack of specificity, uniformity, and quality in data 
collection and reporting procedures.22 Consistent methods for collecting and reporting 
health data can help advance an understanding of the nature of cancer prevention and control 
efforts in the LGBT community, and ultimately lead to public health efforts to reduce those 
disparities and advance health equity.
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